Compare MTNB & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTNB | SPHL |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | 73 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 5.7M |
| IPO Year | 2014 | N/A |
| Metric | MTNB | SPHL |
|---|---|---|
| Price | $0.64 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.8K | ★ 241.2K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $119,750.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $0.35 |
| 52 Week High | $3.09 | $25.11 |
| Indicator | MTNB | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 53.61 |
| Support Level | $0.57 | $2.27 |
| Resistance Level | $0.66 | $5.38 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 11.05 | 49.03 |
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.